imipenem, anhydrous has been researched along with Carcinoma, Large Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hara, N; Hiratsuka, M; Ichikawa, Y; Ishibashi, T; Kido, M; Kondo, Y; Kuroki, S; Kusano, T; Mitsuyama, T; Miyahara, T; Motohiro, A; Nakanishi, Y; Naoe, H; Nikaido, Y; Ninomiya, K; Ohno, T; Oizumi, K; Senju, S; Shigematsu, H; Takamoto, M; Tanaka, H; Ueda, H; Watanabe, K; Yamada, H; Yoshida, M | 1 |
1 trial(s) available for imipenem, anhydrous and Carcinoma, Large Cell
Article | Year |
---|---|
[Clinical efficacy of imipenem/cilastatin sodium for respiratory infections in patients with lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Opportunistic Infections; Respiratory Tract Infections | 1997 |